Altus Capital’s Pfizer PFE Stock Holding History

Altus Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-13,175	Closed	-$389K	–	20
2014 Q4	$389K	Sell	13,175 -35,309	-73%	-$1.01M	1.15%	20
2014 Q3	$1.36M	Sell	48,484 -9,486	-16%	-$266K	2.52%	11
2014 Q2	$1.63M	Sell	57,970 -21,080	-27%	-$601K	2.51%	10
2014 Q1	$2.41M	Sell	79,050 -31,620	-29%	-$943K	3.09%	8
2013 Q4	$3.22M	Hold	110,670	–	–	3.67%	6
2013 Q3	$3.02M	Hold	110,670	–	–	3.45%	8
2013 Q2	$2.94M	Buy	+110,670	New	+$3.06M	3.74%	8

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Altus Capital's PFE Position: Q1 2015 in Review

Altus Capital sold out of Pfizer (PFE) in Q1 2015, closing a stake of 13,175 shares — an estimated $389K sold.

Altus Capital first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $3.22M in Q4 2013. 1,874 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Altus Capital reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
Altus Capital sold 13,175 Pfizer shares in Q1 2015, an estimated $389K.
Altus Capital first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Altus Capital's Pfizer position peaked at $3.22M in Q4 2013.
1,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Altus Capital's 13F filing for Q1 2015, filed 7 May 2015.